retatrutide phase 2 type 2 diabetes trial for 1 Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, people with 🚀Eli Lilly Announces Positive Phase

Clinical Evidence for Retatrutide in Weight Management Potential Side Effects and Safety Considerations Current Availability and Regulatory Status in the UK Who May Be Suitable for Peptide-Based Weight Loss Treatment

Many lipedema patients struggle with weight management because of the distinctive fat deposition patterns

2025 Apr;31(4):1239-45

L-Carnitina e performance atltica Atletas e entusiastas do fitness frequentemente recorrem L-carnitina com o objetivo de melhorar a performance fsica e acelerar a recuperao ps-treino

Understanding the regulatory differences helps patients make informed decisions in consultation with healthcare providers